Phase 3
๐ Investigational Drug / Biologic
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
๐ Clinical Trial Site โ Goodyear, Arizona
View Study & Screener โ